Next Article in Journal
Primed for Discovery: Atomic-Resolution Cryo-EM Structure of a Reovirus Entry Intermediate
Next Article in Special Issue
Ectromelia Virus Infections of Mice as a Model to Support the Licensure of Anti-Orthopoxvirus Therapeutics
Previous Article in Journal
Cell-to-Cell Spread of Retroviruses
Viruses 2010, 2(6), 1322-1339; doi:10.3390/v2061322
Review

Historical Perspectives in the Development of Antiviral Agents Against Poxviruses

Rega Institute for Medical Research, Department of Microbiology and Immunology, Minderbroedersstraat 10, B-3000 Leuven, Belgium
Received: 19 April 2010 / Revised: 28 May 2010 / Accepted: 28 May 2010 / Published: 14 June 2010
(This article belongs to the Special Issue Antivirals Against Poxviruses)
View Full-Text   |   Download PDF [859 KB, uploaded 12 May 2015]   |   Browse Figures

Abstract

The poxvirus vaccinia virus (VV) served as the model virus for which the first antivirals, the thiosemicarbazones, were identified. This dates back to 1950; and, although there is at present no single antiviral drug specifically licensed for the chemotherapy or -prophylaxis of poxvirus infections, numerous candidate compounds have been described over the past 50 years. These compounds include interferon and inducers thereof (i.e., polyacrylic acid), 5-substituted 2’-deoxyuridines (i.e., idoxuridine), IMP dehydrogenase inhibitors, S-adenosylhomocysteine hydrolase inhibitors, acyclic nucleoside phosphonates (such as cidofovir) and alkoxyalkyl prodrugs thereof (such as CMX001), viral egress inhibitors (such as tecovirimat), and cellular kinase inhibitors (such as imatinib).
Keywords: thiosemicarbazones; interferon (inducers); idoxuridine (IDU); acyclic nucleoside phosphonates; cidofovir; CMX001 (HDP-CDV); tecovirimat (ST-246); Gleevec (imatinib) thiosemicarbazones; interferon (inducers); idoxuridine (IDU); acyclic nucleoside phosphonates; cidofovir; CMX001 (HDP-CDV); tecovirimat (ST-246); Gleevec (imatinib)
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Supplementary material

SciFeed

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
EndNote |
RIS
MDPI and ACS Style

De Clercq, E. Historical Perspectives in the Development of Antiviral Agents Against Poxviruses. Viruses 2010, 2, 1322-1339.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here

Comments

[Return to top]
Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert